Abstract:Disulfiram (DSF), a U.S. Food and Drug Administration (FDA)-approved drug for the treatment of chronic alcoholism, is also used as an antitumor drug in combination with Cu2+ ions. However, studies have shown that the endogenous Cu2+ dose in tumor tissues is still insufficient to form relatively high levels of a bis(N,N-diethyldithiocarbamate) copper(II) complex (denoted as Cu(DTC)2) to selectively eradicate cancer cells. Here, DSF-loaded hollow copper sulfide nanoparticles () were designed to achieve tumor microenvironment (TME)-activated in situ formation of cytotoxic Cu(DTC)2 for NIR-II-induced, photonic hyperthermia-enhanced, and DSF-initiated cancer chemotherapy. The acidic TME triggered the gradual degradation of , promoting the rapid release of DSF and Cu2+ ions, causing the in situ formation of cytotoxic Cu(DTC)2, to achieve efficient DSF-based chemotherapy. Additionally, exhibited a notably high photothermal conversion efficiency of 23.8% at the second near-infrared (NIR-II) biowindow, thus significantly inducing photonic hyperthermia to eliminate cancer cells. Both in vitro and in vivo studies confirmed the effective photonic hyperthermia-induced chemotherapeutic efficacy of DSF by integrating the in situ formation of toxic Cu(DTC)2 complexes and evident temperature elevation upon NIR-II laser irradiation. Thus, this study represents a distinctive paradigm of in situ Cu2+ chelation-initiated "nontoxicity-to-toxicity" transformation for photonic hyperthermia-augmented DSF-based cancer chemotherapy.The Supporting Information is available free of charge at <a class="ext-link" href="/doi/10.1021/acsnano.0c08848?goto=supporting-info">https://pubs.acs.org/doi/10.1021/acsnano.0c08848</a>.Size distribution, zeta potential, FTIR spectra, extinction coefficient, photothermal performance, accumulative releasing performance, cell viability, intracellular internalization, cellular apoptosis, mRNA expression, body weight, blood parameters, and H&E staining (<a class="ext-link" href="/doi/suppl/10.1021/acsnano.0c08848/suppl_file/nn0c08848_si_001.pdf">PDF</a>)This article has not yet been cited by other publications.

Drug Delivery: Hollow Copper Sulfide Nanoparticle‐Mediated Transdermal Drug Delivery (small 20/2012)

Hollow copper sulfide nanoparticle-mediated transdermal drug delivery.

Photothermal Intracellular Delivery Using Gold Nanodisk Arrays.

Laser Ablation-Enhanced Transdermal Drug Delivery

All‐Optical Nanoscale Heating and Thermometry with Resonant Dielectric Nanoparticles for Controllable Drug Release in Living Cells

Copper Sulfide Nanoparticles for Photothermal Ablation of Tumor Cells.

Transdermal Photothermal Sterilization and Abscess Elimination Research of BSA‐CuS Nanoparticles in vivo

Laser-Activatable CuS Nanodots to Treat Multidrug-Resistant Bacteria and Release Copper Ion to Accelerate Healing of Infected Chronic Nonhealing Wounds

Laser Activatable CuS Nanodots to Treat Multidrug-Resistant Bacteria and Release Copper Ion to Accelerate Wound Healing for Infected Chronic Nonhealing Wounds.

Hydrophobic Anticancer Drug Delivery by a 980 Nm Laser‐Driven Photothermal Vehicle for Efficient Synergistic Therapy of Cancer Cells in Vivo

Direct Dry-Grinding Synthesis of Monodisperse Lipophilic CuS Nanoparticles

Laser-Assisted Drug Delivery

Copper Selenide Nanocrystals for Photothermal Therapy

Microneedle mediated delivery of nanoparticles into human skin

Copper-nanoparticle-embedded hydrogel for killing bacteria and promoting wound healing with photothermal therapy

Numerical simulation of transdermal delivery of drug nanocarriers using solid microneedles and medicated adhesive patch

Light‐Controlled Precise Delivery of NIR‐Responsive Semiconducting Polymer Nanoparticles with Promoted Vascular Permeability

Injectable thermo-sensitive hydrogel loaded hollow copper sulfide nanoparticles for ROS burst in TME and effective tumor treatment

Nanomedicine Enables Drug-Potency Activation with Tumor Sensitivity and Hyperthermia Synergy in the Second Near-Infrared Biowindow

Extracellular Biosynthesis of Copper Sulfide Nanoparticles by Shewanella Oneidensis MR-1 As a Photothermal Agent.

Combinatorial Photothermal and Immuno Cancer Therapy Using Chitosan-Coated Hollow Copper Sulfide Nanoparticles